Table: begin end state 1 20 cytoplasmic 21 38 transmembrane 39 57 non-cytoplasmic 58 77 transmembrane 78 90 cytoplasmic 91 109 transmembrane 110 115 non-cytoplasmic 116 138 transmembrane 139 148 cytoplasmic 149 171 transmembrane 172 182 non-cytoplasmic 183 203 transmembrane 204 250 cytoplasmic 251 272 transmembrane 273 283 non-cytoplasmic 284 304 transmembrane 305 315 cytoplasmic 316 336 transmembrane 337 341 non-cytoplasmic 342 362 transmembrane 363 372 cytoplasmic 373 394 transmembrane 395 405 non-cytoplasmic 406 426 transmembrane 427 447 cytoplasmic
Input: >BPHYT_RS04765 FitnessBrowser__BFirm:BPHYT_RS04765 MTTQSAGPAGNALHRIATHKAMLRLIPLMCVIYFMSYLDRTNVSLAKARLATDLGISAAA YGLGAGIFFIGYALLEVPSNLVAHRVGPRRWIARIAITWGALSASMMFVQGEWSFYAIRV LLGIAEAGLFPALMYMVTMWFAPQDRSVAVGWIYTAPALALVIGNPLGGAFMQMDGLGGL HGWQWLFLLEGLPTIFVGVLLWFKLPEKPSDARWLSADEARALEARAVPDAAHPGMFSQD WVAALKRPATVLIGLIYFLNQVAFVGLVFFTPAMIQQMHVKSPLMIGVLSSSVGIGFLLG VLVLPRIHRRVTNDCLYLGVLTLGLVTSAILFMSTSVLSTQLLLFVATAFFAGGVLPLYW AIAMKRLHGIQAAAGLAFINTIGLIGGFVGPYLFGLAESASGHSASGFSVVVGASVLGLV LVPLLAKAIQSEGRAASLAEPLLNTES
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server